KR20260017488A - 알레르기 항원 및 그 에피토프 - Google Patents

알레르기 항원 및 그 에피토프

Info

Publication number
KR20260017488A
KR20260017488A KR1020267000997A KR20267000997A KR20260017488A KR 20260017488 A KR20260017488 A KR 20260017488A KR 1020267000997 A KR1020267000997 A KR 1020267000997A KR 20267000997 A KR20267000997 A KR 20267000997A KR 20260017488 A KR20260017488 A KR 20260017488A
Authority
KR
South Korea
Prior art keywords
amino acid
seq
polypeptide
acid sequence
acid residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020267000997A
Other languages
English (en)
Korean (ko)
Inventor
카요코 마츠나가
아키코 야가미
마사시 나카무라
나오시 시모죠
나유 사토
유지 아오키
토모미 사카이
Original Assignee
호유 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 호유 가부시키가이샤 filed Critical 호유 가부시키가이샤
Publication of KR20260017488A publication Critical patent/KR20260017488A/ko
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
    • A23L5/20—Removal of unwanted matter, e.g. deodorisation or detoxification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43508—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from crustaceans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Insects & Arthropods (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
KR1020267000997A 2017-04-28 2018-05-01 알레르기 항원 및 그 에피토프 Pending KR20260017488A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017090438 2017-04-28
JPJP-P-2017-090438 2017-04-28
PCT/JP2018/017472 WO2018199341A1 (ja) 2017-04-28 2018-05-01 アレルギーの抗原およびそのエピトープ
KR1020197032673A KR20200002888A (ko) 2017-04-28 2018-05-01 알레르기 항원 및 그 에피토프

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197032673A Division KR20200002888A (ko) 2017-04-28 2018-05-01 알레르기 항원 및 그 에피토프

Publications (1)

Publication Number Publication Date
KR20260017488A true KR20260017488A (ko) 2026-02-05

Family

ID=63919715

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020267000997A Pending KR20260017488A (ko) 2017-04-28 2018-05-01 알레르기 항원 및 그 에피토프
KR1020197032673A Ceased KR20200002888A (ko) 2017-04-28 2018-05-01 알레르기 항원 및 그 에피토프

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197032673A Ceased KR20200002888A (ko) 2017-04-28 2018-05-01 알레르기 항원 및 그 에피토프

Country Status (6)

Country Link
US (2) US20200188510A1 (cg-RX-API-DMAC7.html)
EP (1) EP3617312B1 (cg-RX-API-DMAC7.html)
JP (4) JP7184259B2 (cg-RX-API-DMAC7.html)
KR (2) KR20260017488A (cg-RX-API-DMAC7.html)
CN (2) CN110799646B (cg-RX-API-DMAC7.html)
WO (1) WO2018199341A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3049051T3 (en) 2019-07-22 2025-12-12 Oneskin Inc Polypeptides having anti-senescent effects and uses thereof
US20230251269A1 (en) * 2020-07-15 2023-08-10 The Johns Hopkins University Comprehensive analysis of anti-allergen antibodies using phage display
CN115974994B (zh) * 2022-10-08 2025-09-05 汕头大学 一种来源于凡纳对虾血蓝蛋白的降低血氨毒性及浓度的降解片段PvHMCs27及其应用
CN115963273B (zh) * 2022-10-09 2024-04-12 中国海洋大学 一种三疣梭子蟹nSCP或rSCP的应用与试剂盒
EP4635973A1 (en) * 2022-12-16 2025-10-22 Toagosei Co., Ltd. Synthetic peptide and construct
KR102803104B1 (ko) * 2023-05-15 2025-05-09 아주대학교산학협력단 새우에 대한 아나필락시스 진단용 바이오마커 조성물 및 이의 용도
CN120818579B (zh) * 2025-07-14 2026-06-23 广东海洋大学 一种具有抗冻活性的虾头水解产物及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002286716A (ja) 2001-03-28 2002-10-03 Iatron Lab Inc 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
JP2011033547A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 2次元電気泳動方法
JP2011033548A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 2次元電気泳動方法
JP2011033546A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 等電点電気泳動方法及び粗雑物除去の判定方法
JP2011033544A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 等電点電気泳動用ゲル及び等電点電気泳動方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5449669A (en) * 1993-11-10 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services IgE-binding epitopes of a major heat-stable crustacean allergen derived from shrimp
AU2002352976B2 (en) * 2002-11-27 2007-11-08 Agensys, Inc. Nucleic acid corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
US20060210590A1 (en) * 2005-02-03 2006-09-21 Alk-Abello A/S Minor allergen control to increase safety of immunotherapy
JP4444306B2 (ja) * 2007-04-05 2010-03-31 博 宮澤 エビアレルゲン及び抗エビアレルゲン抗体並びにその利用
US20120219545A1 (en) * 2009-07-31 2012-08-30 Mount Sinai School Of Medicine Materials and methods for diagnosing and treating shellfish allergy
BR112014019504A2 (pt) * 2012-02-07 2017-06-27 La Jolla Inst Allergy & Immunology alérgenos da erva-dos-prados e métodos e usos para modulação de resposta imune
EP4001920A1 (en) * 2014-04-03 2022-05-25 AllerGenis, LLC Peptides and methods for detecting food allergy
WO2016183500A1 (en) 2015-05-14 2016-11-17 La Jolla Institute For Allergy And Immunology Novel antigens and t cell epitopes from cockroach and methods of making and using same
JP5894695B1 (ja) * 2015-05-25 2016-03-30 ホーユー株式会社 ウズラの卵アレルギーの抗原

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002286716A (ja) 2001-03-28 2002-10-03 Iatron Lab Inc 複数項目同時分析可能なイムノクロマトグラフ法及びイムノクロマトグラフ用ストリップ
JP2011033547A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 2次元電気泳動方法
JP2011033548A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 2次元電気泳動方法
JP2011033546A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 等電点電気泳動方法及び粗雑物除去の判定方法
JP2011033544A (ja) 2009-08-04 2011-02-17 Hoyu Co Ltd 等電点電気泳動用ゲル及び等電点電気泳動方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Matsuo, H., et al., J. Biol. Chem., (2004), Vol.279, No.13, pp.12135-12140

Also Published As

Publication number Publication date
JPWO2018199341A1 (ja) 2020-03-26
EP3617312A1 (en) 2020-03-04
US20200188510A1 (en) 2020-06-18
EP3617312A4 (en) 2021-04-07
CN110799646A (zh) 2020-02-14
JP2024026181A (ja) 2024-02-28
US20240108719A1 (en) 2024-04-04
EP3617312B1 (en) 2026-02-18
KR20200002888A (ko) 2020-01-08
CN110799646B (zh) 2024-10-22
EP3617312C0 (en) 2026-02-18
JP7184259B2 (ja) 2022-12-06
EP3617312A8 (en) 2020-04-29
JP2023027061A (ja) 2023-03-01
CN119086940A (zh) 2024-12-06
WO2018199341A1 (ja) 2018-11-01
JP2025118770A (ja) 2025-08-13

Similar Documents

Publication Publication Date Title
CN110799646B (zh) 变态反应的抗原及其表位
JP7834292B2 (ja) アレルギーの抗原およびそのエピトープ
CN111051336B (zh) 变态反应的抗原及其表位
US20230295251A1 (en) Allergy antigen and epitope for same
KR102102031B1 (ko) 메추리알 알레르기의 항원
JP2025093999A (ja) 牛乳アレルギーの新規抗原
KR20210095986A (ko) 알레르기 항원 및 그 에피토프

Legal Events

Date Code Title Description
A16 Divisional, continuation or continuation in part application filed

Free format text: ST27 STATUS EVENT CODE: A-0-1-A10-A16-DIV-PA0104 (AS PROVIDED BY THE NATIONAL OFFICE)

PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

Q12 Application published

Free format text: ST27 STATUS EVENT CODE: A-1-1-Q10-Q12-NAP-PG1501 (AS PROVIDED BY THE NATIONAL OFFICE)

E13 Pre-grant limitation requested

Free format text: ST27 STATUS EVENT CODE: A-2-3-E10-E13-LIM-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13 Application amended

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

P11 Amendment of application requested

Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-NAP-X000 (AS PROVIDED BY THE NATIONAL OFFICE)

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000